Mapping of a novel susceptibility locus suggests a role for MC3R and CTSZ in human tuberculosis by Cooke, GS et al.
  
Mapping of a Novel Susceptibility Locus Suggests a Role for MC3R and CTSZ 
in Human Tuberculosis 
 
Graham S. Cooke,1,2,3 Sarah J. Campbell,1 Steve Bennett,4,† Christian Lienhardt,5 Keith P. W. J. 
McAdam,6 Giorgio Sirugo,6 Oumou Sow,7 Per Gustafson,8 Frank Mwangulu,9,† Paul van Helden,10 Paul 
Fine,9 Eileen G. Hoal,10 and Adrian V. S. Hill1 
1Wellcome Trust Centre for Human Genetics, University of Oxford, Churchill Hospital, Headington, 
Oxford, United Kingdom;  
2Imperial College, London, United Kingdom;  
3Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Somkhele, South 
Africa;  
4London School of Hygiene and Tropical Medicine, London, United Kingdom;  
5National TB/Leprosy Control Programme, Banjul, The Gambia;  
6Medical Research Council Laboratories, Fajara, The Gambia;  
7CHU Ignace Deen, Conakry, Guinea;  
8Danish Epidemiology Science Centre, Bissau, Guinea-Bissau;  
9Karonga Prevention Study, Chilumba, Malawi; and  
10Medical Research Council Centre for Molecular and Cellular Biology, Stellenbosch University, South 
Africa 
†These authors have passed away since the inception of the project. 
Correspondence and requests for reprints should be addressed to Graham S. Cooke, Ph.D., M.R.C.P., 
Africa Centre for Health and Population Studies, PO Box 198, Mtubatuba 3935, Somkhele, KwaZulu-
Natal, South Africa. E-mail: az.ca.ertnecacirfa@ekoocg 
 
  
Abstract 
 
Rationale: Tuberculosis remains a major cause of morbidity and mortality in the developing world. A 
better understanding of the mechanisms of disease protection could allow novel strategies to 
disease management and control. 
Objectives: To identify human genomic loci with evidence of linkage to tuberculosis susceptibility 
and, within these loci, to identify individual genes influencing tuberculosis susceptibility. 
Methods: Affected sibling pair analysis in South African and Malawian populations. Independent 
case-control study in West Africa. 
Measurements and Main Results: Two novel putative loci for tuberculosis susceptibility are 
identified: chromosome 6p21-q23 and chromosome 20q13.31—33—the latter with the strongest 
evidence for any locus reported to date in human tuberculosis (single point LOD score of 3.1, P = 
10−4, with a maximum likelihood score [MLS] of 2.8). An independent, mulƟstage geneƟc 
association study in West African populations mapped this latter region in detail, finding evidence 
that variation in the melanocortin 3 receptor (MC3R) and cathepsin Z (CTSZ) genes play a role in the 
pathogenesis of tuberculosis. 
Conclusions: These results demonstrate how a genomewide approach to the complex phenotype of 
human tuberculosis can identify novel targets for further research. 
 
 
Interest in human susceptibility to tuberculosis predates the discovery of the causative pathogen. 
Evidence has accumulated from a number of sources that human genetics influences an individual's 
susceptibility to disease and in recent years some of the genes responsible have been identified, 
most notably HLA class II (1–3), natural resistance-associated macrophage protein-1 (NRAMP1) (4–
8), interferon gamma (IFNG) (9–11), and MYD88 adaptor-like (MAL) (12). These successes have 
generally used a candidate gene approach based on knowledge of human immunology gained from 
bench, animal, and human studies. 
Genomewide linkage studies offer the promise of discovering genes influencing disease susceptibility 
for which a role might not have been previously suspected. To date, despite success in the closely 
related disease of leprosy (13–16), genomewide linkage studies have failed to identify a major 
susceptibility locus for tuberculosis. Previous work in a South American study (17) found the 
strongest evidence for linkage in the genomic regions 20p12.1 and 17q11–21, and work in African 
populations (18) has implicated the regions 15q11–13 (19) and Xq27 (20). 
We performed further affected sibling pair linkage analysis in two populations: “Coloureds” (South 
Africans of mixed racial origin) from metropolitan Cape Town and Malawians from the Karonga 
district. One genomic region, 20q13.31–33, was prioritized for further study. With a two-stage 
design, this region was then mapped in detail in a large, independent West African case-control 
study, with the aim of identifying novel loci involved in the pathogenesis of disease. 
METHODS 
Family Recruitment 
Families for genomewide analysis were recruited from the Coloured population in metropolitan 
Cape Town, South Africa. A total of 131 sibling pairs were identified in 81 families with pulmonary 
tuberculosis, defined by either a positive sputum smear or positive mycobacterial culture. Twenty-
four sibling pairs were identified in 24 families recruited from the Karonga Prevention Study in 
Malawi. Where possible, DNA was also collected from both parents. When this was not possible, 
DNA from unaffected siblings was collected to allow reconstruction of parental genotypes. All 
individuals gave informed consent for their samples to be used for genetic analysis. Approvals were 
obtained from local ethics committees (University of Oxford, UK; Gambian Government/Medical 
Research Council Ethical Committee; Ministry of Public Health, Guinea-Bissau; National Ethics 
Committee, Ministry of Health, Conakry, Guinea; and the ethics committee of the Faculty of Health 
Sciences, Stellenbosch University, South Africa). 
Microsatellite Genotyping 
A commercially available set of microsatellite markers (LMSv2 MD10; Applied Biosystems, Foster 
City, CA) was used for genomewide linkage analysis. Individual markers were amplified with a range 
of annealing temperatures (55°–61°C) and Mg concentrations (1.5–2.5 mM Mg2+) in a 15-μl reaction 
mix containing 50 ng of DNA, 40 ng of each primer, 2.5 mmol KCl buffer, 100 μM dNTPs, and 0.2 U 
Taq polymerase. Details of primers and conditions are available from the authors on request. FAM-
labeled products were pooled separately from HEX/NED-labeled products to avoid spectral overlap 
and analyzed with the AB 3700 system. Genotypes were extracted using Genotyper software 
(Genotyper Version 2; Applied Biosystems). 
Statistical Methods 
Pedigrees were checked for nonpaternity with GAS (Oxford University, Oxford, UK) and PedCheck 
(University of Pittsburgh, Pittsburgh, PA) (21). LOD (logarithm of the odds) scores for individual 
markers were estimated with the Sibpair analysis program (Queensland Institute of Medical 
Research, Queensland, Australia) (22). Sibpair analysis provides a likelihood-based statistic for 
linkage that is equivalent to the LOD score calculated assuming recessive disease with the phase 
unknown. If parents were unavailable, the likelihood is calculated using the sum of terms 
corresponding to each possible parental genotype combination calculated assuming Hardy-
Weinberg equilibrium (HWE). The method is a nonparametric approach, which is preferred because 
the mode of inheritance for any putative disease susceptibility allele is unknown. Exclusion mapping 
was performed with a parametric method such that areas of the genome with sufficiently low LOD 
scores can be excluded from containing a gene of interest with a specified lambda-s. 
Maximum likelihood multipoint mapping was performed with the Mapmaker/Sibs program 
(Whitehead Institute for Biomedical Research, Cambridge, MA) (23) to increase the information 
content at any given locus. Only fully independent sibling pairs were analyzed and maximum 
likelihood scores calculated using Holman's constraints (24). Multipoint data were assessed for 
possible errors in genotyping using PEDwipe, part of the Merlin program (University of Michigan, 
Ann Arbor, MI) (25). 
Analysis 
An initial genomewide screen was performed on 71 sibling pairs with 402 polymorphic microsatellite 
markers spanning the genome. Thirty-nine sibling pairs had been part of a previous study (18), and 
for these samples, markers in 15q11-13 and Xq27 were excluded from analysis. Markers for which 
linkage could not be excluded were subsequently analyzed in the remaining 60 sibling pairs. Regions 
with evidence for linkage were then studied in the Malawi population and data combined to 
prioritize regions for further study. 
Case-Control Study 
Detailed single nucleotide polymorphism (SNP) mapping was performed as part of a large, 
independent case-control study of adult pulmonary tuberculosis from West Africa, described in 
detail previously (26, 27). The study includes population collections from The Gambia, Guinea-
Bissau, and Guinea. All cases had been confirmed by either two consecutive smear-positive samples 
or a positive mycobacterial culture. Both HIV-positive and HIV-negative cases were included, the 
prevalence of each differing between countries, and with prevalence ranging from 2 to 8.1% 
between countries (26). For further testing, samples were included from another Gambian case-
control study (4). A test of HWE was applied to the control population for each SNP. Unless noted, 
SNPs did not deviate from HWE. In view of the large number of SNPs being tested for association, 
and the potential pitfalls of multiple testing, a multistage strategy was adopted. The Gambian cohort 
within the TB, Genetics, and Environment study (TBGENENV) study was investigated first, with 
significant findings followed up in other remaining populations. 
SNP Typing 
Within a 1-LOD support region around the peak of linkage, a cluster of genes lying between 
microsatellite markers d20s832 and d20s173 were prioritized for study. Forty SNPs from this region 
were identified from publicly available databases. All SNPs were typed using the MassArray platform 
(Sequenom, San Diego, CA) using the manufacturer's recommended protocols. The seven exons and 
the 3′ untranslated region (3′UTR) of cathepsin Z (CTSZ) were sequenced as separate polymerase 
chain reaction products and analyzed on the ABI 3700 system using SeqMan software (DNAStar, 
Madison, WI) (primers and conditions for all reactions available from authors on request). SPSS 
version 11 (SPSS, Inc., Chicago, IL) was used to perform binary logistic regression to assess the effect 
of genotype on disease outcome, adjusted for age, sex, ethnicity, and HIV status. 
RESULTS 
Genomewide Analysis 
Using an LOD score of less than or equal to −2 as a threshold for exclusion, over 40% of the genome 
was found unlikely to contain a putative disease susceptibility locus with a locus-specific λs of 2 or 
more. The first-round genome screen identified 64 markers that were followed up for further 
analysis. 
A novel region, not previously studied in this population, was identified on chromosome 6 (6p21-
6q23) with evidence for linkage found in both stages of the genomewide screen. The highest single 
point of linkage was found at marker d6s434 (single point LOD, 1.9; MLS, 1.82; P = 0.002). Evidence 
for linkage was found within the region of 15q11-13, identified in previous work (18), and including 
samples previously analyzed, an MLS (LOD) score of 2.1 is found in the Coloured population alone. 
Further evidence suggesting linkage was identified in regions including 20q31-33 (LOD score on first 
round, 0.9; overall MLS, 0.6) and 14q31-32 (LOD, 1.1 on first screen; overall MLS, 0.9). There was 
weak evidence for linkage in the region 17p11.2-17q11.2 (MLS, 0.6). 
Twelve markers used in the complete genome screen were then selected for study in the Malawian 
population. These 12 markers were drawn from the LMSv2 and chosen if they fell within the regions 
of suggestive linkage on chromosomes 6p21-q23, 15q11-13, 20q13.31—33, and Xq27. A list of these 
markers is available from the authors. Two of these markers were within the putative region of 
linkage on chromosome 20 (d20s171 and d20s173); d20s171 showed evidence of linkage (LOD, 2.0; 
P = 0.0005) with some weak evidence for d20s173 (LOD, 0.91; P = 0.91). 
To prioritize regions for further study, all markers typed with the same primers were analyzed 
together with families studied previously (18) as a single dataset. The strongest evidence for linkage 
was within the region 20q13.31-33 (with an MLS of 2.8 on multipoint mapping, P = 0.00008; see 
Figure 1). 
Figure 1. 
 
Multipoint mapping of chromosome 20 for all populations studied. Peak of 
linkage corresponds to marker 20s171. 
 
Detailed Association Mapping of 20q30.31-33 
In an initial screen of 40 SNPs, polymorphism within two genes showed evidence of disease 
association in the Gambia: melanocortin 3 receptor (MC3R; rs3827103 referred to here as MC3R241) 
encoding MC3R (MC3R241 genotype AA protective, P = 0.04) and CTSZ (GenBank SNP NM_011362 
[refSNIP rs34069356; National Center for Biotechnology Information, Bethesda, MD] referred to 
here as CTSZ3P) encoding cathepsin Z (CTSZ3P genotype CC susceptible, P = 0.01). Associated 
polymorphisms within these genes were typed in the populations of Guinea-Bissau and Guinea. 
CTSZ 
The genotype distributions of CTSZ3P were similar in all three populations and combined analysis 
found significant evidence of disease association among cases (CC genotype 386 [58.0%], CT 255 
[38.3%], and TT 24 [3.6%]) versus controls (316 [52.9%], 236 [39.5%], and 45 [7.5%], respectively). 
These results were significant when regression analysis was performed to correct for age, sex, 
ethnicity, and HIV status (odds ratio [OR] of TT genotype for disease, 0.49; 95% confidence interval 
[CI], 0.29–0.84; P = 0.009). 
Genotyping was repeated to confirm the results and 90 cases and control subjects were sequenced 
to validate the genotypes. Once strong disease association was confirmed within the 3′UTR SNP, 
sequencing was extended to the gene's coding exons and other neighboring markers were examined 
in more detail. Only one nonsynonymous SNP was identified within CTSZ (in exon 5), but this showed 
no evidence of disease association (P = 0.31). 
MC3R 
Over the three populations studied, the trend to protective effect for the MC3R genotype AA 
remained between cases (AA genotype 142 [20.4%], AG 357 [51.3%], and GG 197 [28.3%]) versus 
control subjects (156 [24.1%], 314 [48.5%], and 178 [27.5%], respectively). However, regression 
analysis was nonsignificant (P = 0.26). Genotyping was confirmed by direct sequencing of the single 
exon of MC3R. 
In light of the association seen in the Gambian population within TBGENENV, further genotyping was 
done in samples from a previous study (4). This independent dataset also found evidence of a 
protective role for the MC3R241 AA genotype. Genotypes found in cases were AA 63 (22.2%), AG 
137 (48.2%), and GG 84 (29.6%), and in control subjects were AA 53 (30.9%), AG 68 (39.7%), and GG 
50 (29.2%); OR for the AA genotype, 0.63; 95% CI, 0.40–1.00; P = 0.04. Combining the two Gambian 
populations found a stronger protective effect (OR, 0.67; 95% CI, 0.50–0.88; P = 0.004). 
 
DISCUSSION 
 
There are two key aspects to these results: the first is the novel identification of a major locus for 
susceptibility to human pulmonary tuberculosis on chromosome 20; the second is the identification 
of two susceptibility genes with a plausible link to tuberculosis, both of which merit further study. 
The great attraction of linkage analysis remains that, starting from clinical cases of disease, and with 
no prior hypothesis of disease immunology, it is possible to identify previously unsuspected 
molecules playing a role in disease. For tuberculosis, there are three potential susceptibility loci that 
have been studied in detail to date. Those on 15q11-13 and Xq27 (18) have the most statistically 
convincing evidence of linkage in published work to date. The former has already been the subject of 
some preliminary mapping (19) with the gene UBE3A implicated in disease. Key candidates within 
Xq27 have also been investigated and no disease association was established for either of two 
candidate genes prioritized on the basis of their position and function, CD40 ligand, and iduronate 2-
sulphatase (IDS) (20). More recently, detailed mapping within a locus on chromosome 17q11-q21 
has found disease association with several genetic variants within one gene cluster (28), which could 
not be resolved more finely. 
The data presented here suggest two novel putative tuberculosis susceptibility loci in African 
populations, 6p21-23 and 20q13.31-33. The latter presents the strongest evidence for linkage yet 
with the complex phenotype of tuberculosis. The challenge of finding disease association beyond the 
original dataset can often be difficult and confounded by the problems of multiple testing. The 
multistage strategy described here finds evidence of disease association within the gene encoding 
cathepsin Z, a member of the cathepsin protease family, and MC3R, a member of the melanocortin 
receptor (MCR) family. 
The cathepsins are a family of cysteine proteases, which form a major component of the lysosomal 
proteolytic system and thus potentially have a role in immunity to pathogens including 
Mycobacterium tuberculosis. Endosomal proteases have a role in two elements of major 
histocompatibility class II–restricted antigen presentation: antigen degradation and invariant chain 
cleavage. 
The gene encoding cathepsin Z was cloned after a search for homologs of the then-known 
cathepsins (29). The enzyme, 303 amino acids in length, has significant similarity to cathepsin B 
(26%), cathepsin C (34%), and cathepsin L (30). However, the observations that the enzyme differs 
significantly from other cathepsins with a shorter leader propeptide, a more diverse array of 
insertions around the active site, and an unusual chromosomal location led the authors to suggest it 
might be a member of an independent cathepsin subfamily. It is encoded by a gene within the 
region 20q13.31-33. 
To date, evidence supporting a role for cathepsin Z in tuberculosis has been inferred from an 
appreciation of its role in macrophages and by analogy to other cathepsins. Cathepsin Z is one of 
only two cathepsins preferentially expressed in murine macrophages (the other is cathepsin F) (31). 
It is recruited to the murine phagosome and is found there hours after phagocytosis (32). Using 
murine primary macrophage cell lines (J774), Lennon-Dumenil and colleagues monitored the 
sequential recruitment and activation of cathepsins to the phagosome. They found that cathepsin Z 
was one of the four most abundant cysteine proteases present and active in early phagosomal 
compartments, despite its relatively mild pH, in contrast to other cathepsins that were recruited 
later (33). That this pattern of recruitment and activation was not observed in a dendritic cell line 
suggests that the role of cathepsin Z might be specialized to macrophages and, by analogy to other 
cathepsins, host defense. In contrast to a role in protective immunity, cathepsin Z could mediate 
tissue damage by degradation of the extracellular matrix. For example, it has been reported that 
cathepsin Z is strongly overexpressed in malignant melanoma cells and could play a role in allowing 
tumors to metastasize. 
MC3R is part of a wider family of MCRs that have been of key interest in the study of obesity and 
weight control. They respond to natural melanocortin proteins derived from the larger molecule 
POMC (pro-opiomelanocortin), and share a single amino acid motif (HFRW sequence). The MC3R 
protein is 361 amino acids long and encoded by a single exon on 20q13.2. The molecule is a G-
protein–coupled membrane receptor with seven transmembrane domains. 
 The different receptors within the MCR family differ in their specificity for particular POMC 
derivatives (34), their tissue expression, and their biological effects once activated. MC3R differs 
from the other melanocortins in that it has no selective specificity for melanocortin-derived products 
and is the only MCR strongly activated by γ-MSH (gamma melanocyte-stimulating hormone). 
Beyond energy homeostasis, it has been realized for some time that derivatives of POMC have 
antiinflammatory effects in a variety of animal models of inflammation, including mycobacterial 
arthritis (35, 36). MC1R was originally believed to be the key family member playing a role in 
inflammatory responses, mediating the proinflammatory effects of γ-MSH in monocytes. However, 
recent work from Getting and colleagues suggests a more important role for MC3R (37). Getting and 
coworkers (38, 39) have used a murine model of gouty inflammation to show that inhibition of 
MC3R reduces the response of peritoneal monocytes to an injection of urate crystals and, more 
recently, that it reduces the inflammatory reaction in a model of gouty arthritis (40). Although the 
functional relevance of the associated SNP cannot be inferred from this associated study, it is 
possible that the MC3R241 AA genotype is associated with a loss of function that might allow a more 
vigorous inflammatory response to control infection. 
The size of the effects seen for both CTSZ and MC3R means it is very unlikely that variation in either 
gene plays a major role in tuberculosis, at least in the populations studied. However, these results 
are the first direct suggestion of a role for members of either the cathepsin family or the MCRs in the 
pathogenesis of tuberculosis, a hypothesis that can now be tested in genetic, cellular, and clinical 
studies, and that offers potentially important insights into the pathogenesis of this persistent 
disease. 
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